|Other Accession||Q8BFQ6, NP_116228.1|
|Other Names||Disrupted in renal carcinoma protein 2, Disrupted in renal cancer protein 2, DIRC2|
|Target/Specificity||The synthetic peptide sequence is selected from aa 217-229 of HUMAN DIRC2|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Electrogenic metabolite transporter.|
|Cellular Location||Lysosome membrane; Multi-pass membrane protein|
|Tissue Location||Ubiquitous. Expressed in proximal tubular cells of the kidney.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
This gene encodes a membrane-bound protein from the major facilitator superfamily of transporters. Disruption of this gene by translocation has been associated with haplo-insufficiency and renal cell carcinomas. Alternatively spliced transcript variants have been described, but their biological validity has not yet been determined.
Bodmer, D., et al. Cancer Genet. Cytogenet. 136(2):95-100(2002)
Bodmer, D., et al. Hum. Mol. Genet. 11(6):641-649(2002)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.